UKpancreatic cancerPancreatic atrophyPERTPancreatic exocrine insufficiencypancreatic diseasePEI
…ic exocrine insufficiency (PEI) is common in pancreatic cancer; UK consensus guidance recommends empirical pancreatic enzyme repla…
11,350articles mentioning institutions
22,378institution mentions
9,137distinct institutions extracted
0%of mentions human-reviewed
All extracted institutions
Showing 1,081–1,140 of 9,137, ordered by supporting articles. Choose a institution to see its evidence.
American College of Radiology2American College of Surgeons-verified Level 1 trauma center2American Joint Committee on Cancer2American Psychological Association2American Society of Anesthesiologists2American Society of Regional Anesthesia and Pain Medicine2American University of Beirut Medical Center2Ankara University School of Medicine Department of Pediatrics2Arch Pathol Lab Med2Ariadne Labs2Arksey and O’Malley2Arnhold Institute for Global Health2Asia Pacific Lupus Collaboration2Association for Computing Machinery2Association of American Medical Colleges2Audiology2Australian Bureau of Statistics2Australian New Zealand Clinical Trial Registry2Australian Scleroderma Cohort Study2Australian hospitals2Azienda Ospedaliero-Universitaria Policlinico di Modena2BHF Data Science Centre2BJSM2BLISS-762BMC Geriatr2BMC Med 20242BMC Nurs 20242BMC Psychiatry2BMJ Leader2BMJ Military Health2BMJ Open Gastroenterology2BMJ Open Quality2BMJ Open Respiratory Research2Bali International Hospital2Balt2Bangladesh Medical Research Council2Basildon Hospital2Basingstoke and North Hampshire Hospital2Beijing Sport University2Beijing Tiantan Hospital2Beijing Tongren Hospital2BenRex2Bern University Hospital2BioMed Central2BioMed Research International2Biobank UK2Biotronik2Blueteq2Boateng et al2Bond University2Borvo Medical, Inc2Boston University2Br J Cardiol2Br J Psychiatry2Brainomix2Braun and Clarke2British Education Index2British Medical Journal2British Pregnancy Advisory Service2CABI2
Articles mentioning institutions
11,350 articles · page 434 of 946NCT03926130MirikizumabMIRICrohn’s disease
… from patients randomised to MIRI in the Phase 3 VIVID-1 study (NCT03926130) who attained endoscopic response at week 52 (W52) and continue…
NCT04996797Original Geboes ScoreTulisokibartulcerative colitis
…he phase 2, double-blind, placebo-controlled ARTEMIS-UC study ( NCT04996797). We assessed symptomatic relief through changes in stool frequ…
96.8%
Edinburgh IBD UnitfilgotinibUCproctitisHerpes Zosterrecombinant zoster vaccination
…C cohort.Methods All UC patients treated with filgotinib at the Edinburgh IBD Unit with a minimum of 12 months since drug commencement were assess…
N Engl J MedCrohn’s diseaseUPA15UPA30CDUPA30-treated
…tis. (Abstract). 2024;18:i17–i18.Loftus EV Jr., Panés J, et al. N Engl J Med. 2023;88:1966–80.…
tertiary referral centrechronic obstructive pulmonary diseasemidazolamtype 2 diabetes mellitusfentanylchronic kidney disease/end-stage renal disease
…se patients experiencing CS failure during dEUS procedures at a tertiary referral centre.Methods A retrospective analysis was conducted on all patients …
UniprotIBDUlcerative ColitisCrohn’s disease
…ipe (v22.0) and were searched against a human protein database (Uniprot). Further proteomic and statistical analysis was performed usin…
NCT06050811IBD-Control QuestionnaireSimple Clinical Colitis Activity IndexUlcerative Colitis
…charide (HMO) 2’-fucosyllactose (2’-FL) in mild-to-moderate UC (NCT06050811).Methods 38 participants with mild-to-moderate UC and objective…
82.7%
Cambridge University HospitalsAdalimumabTofacitinibGolimumabInfliximabVedolizumabUstekinumabulcerative colitisIBDIBD-U+1 more
…ive cohort study of all patients with a diagnosis of IBD in the Cambridge University Hospitals electronic medical record. Socioeconomic disadvantage was quant…
89.2%
Leeds Teaching Hospitals NHS TrustHospital Anxiety and Depression Scaleinflammatory bowel diseaseulcerative colitisIBDCrohn’s disease
…scopic, histological or radiological findings were recruited at Leeds Teaching Hospitals NHS Trust from March 2023 to September 2025. Demographic, disease-related…
NCT06294925EtrasimodNumeric Rating Scaleulcerative colitisUC
…a for etrasimod up to 24 weeks of treatment.Methods EFFECT-UC ( NCT06294925) is an ongoing, prospective, multinational, non-interventional …
Johnson & JohnsonGuselkumabulcerative colitisGUSGUS-treated
…ved at W92 of the LTE with both GUS dose regimens.Study Support Johnson & Johnson.References Rubin DT, et al. Guselkumab in patients with moderat…